DHR
35
3
ILMN
32
-3
ETR
68
3
PVH
52
-3
PX
75
5
MDLZ
34
2
LB
34
8
BEN
45
3
BA
52
2
BBY
40
3
PSA
51
-4
ABT
57
-5
MPC
47
3
LH
42
2
RRC
63
3
HRL
39
15
BAC
50
-3
STI
47
-12
KR
34
-3
TDC
75
4
DHR
35
3
ILMN
32
-3
ETR
68
3
PVH
52
-3
PX
75
5
MDLZ
34
2
LB
34
8
BEN
45
3
BA
52
2
BBY
40
3
PSA
51
-4
ABT
57
-5
MPC
47
3
LH
42
2
RRC
63
3
HRL
39
15
BAC
50
-3
STI
47
-12
KR
34
-3
TDC
75
4
Financhill
Back

SpringWorks Therapeutics Quote, Financials, Valuation and Earnings

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here
Buy
53

SWTX
SpringWorks Therapeutics

Last Price:
36.65
Seasonality Move:
51.03%

7 Day Trial

ALL ACCESS PASS

$ 7

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.

SpringWorks Therapeutics Price Quote

$36.65
-0.79 (-2.11%)
(Updated: November 21, 2024 at 11:35 AM ET)

SpringWorks Therapeutics Key Stats

Buy
53
SpringWorks Therapeutics (SWTX) is a Buy
Day range:
$36.75 - $38.58
52-week range:
$20.19 - $53.92
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
18.33
P/B ratio:
4.83%
Volume:
1.2M
Avg. volume:
1.2M
1-year change:
68.5%
Market cap:
$2.6B
Revenue:
$5.4M
EPS:
$-3.89

How Much Does SpringWorks Therapeutics Make?

Is SpringWorks Therapeutics Growing As A Company?

Data Unavailable

SpringWorks Therapeutics Stock Price Performance

What Is SpringWorks Therapeutics 52-Week High & Low?

SpringWorks Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy SpringWorks Therapeutics?

Is SpringWorks Therapeutics Cash Flow Positive?

  • What Is SWTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$208.8M
  • What Is SpringWorks Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $303.2M
  • What Is SpringWorks Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$108.8M

SpringWorks Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    SWTX return on invested capital is -51.38%
  • What Is SpringWorks Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -44.72%
  • What Is SWTX Return On Equity?
    ROE is a measure of profitability and is -51.38%

SpringWorks Therapeutics Earnings Date & Stock Price

SpringWorks Therapeutics Competitors

SpringWorks Therapeutics Dividend Yield

SpringWorks Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 5.26%
Revenue: 0% -10.59%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 68.00
Upside from Last Price: 81.62%

Major Shareholders

  • How many SWTX shares are owned by institutional investors?
    135.2M SWTX shares are owned by institutional investors
  • How many SWTX shares are owned by insiders?
    2.9M SWTX shares are owned by insiders